HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diminished amyloid-beta burden in Tg2576 mice following a prophylactic oral immunization with a salmonella-based amyloid-beta derivative vaccine.

Abstract
Immunotherapy holds great promise for Alzheimer's disease (AD) and other conformational disorders but certain adverse reactions need to be overcome. Prior to the side effects in the first Elan/Wyeth AD vaccine trial, we proposed using amyloid-beta (Abeta) derivatives as a safer approach. The route of administration may also affect vaccine safety. To assess the feasibility of oral immunization that promotes mucosal immunity, Tg2576 AD model mice were treated prophylactically three times over 6 weeks starting at 3-5 months of age with a Salmonella vaccine expressing K6Abeta(1-30). At 22-24 months of age, cortical Abeta plaque burden and total Abeta(40/42) levels were reduced by 48-75% in the immunized mice compared to controls, which received unmodified Salmonella. Plaque clearance was not associated with increased microglial activation, which may be explained by the long treatment period. Furthermore, cerebral microhemorrhages were not increased in the treated mice in contrast to several passive Abeta antibody studies. These results further support our findings with this immunogen delivered subcutaneously and demonstrate its efficacy when given orally, which may provide added benefits for human use.
AuthorsAllal Boutajangout, Fernando Goni, Elin Knudsen, Fernanda Schreiber, Ayodeji Asuni, David Quartermain, Blas Frangione, Alejandro Chabalgoity, Thomas Wisniewski, Einar M Sigurdsson
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 18 Issue 4 Pg. 961-72 ( 2009) ISSN: 1875-8908 [Electronic] Netherlands
PMID19749432 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Alzheimer Vaccines
  • Amyloid beta-Peptides
  • Immunoglobulins
  • Peptide Fragments
  • Vaccines, Synthetic
Topics
  • Administration, Oral
  • Alzheimer Disease (prevention & control)
  • Alzheimer Vaccines (administration & dosage, immunology)
  • Amyloid beta-Peptides (immunology)
  • Animals
  • Cerebral Hemorrhage (etiology, prevention & control)
  • Disease Models, Animal
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Immunoglobulins (blood)
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Transgenic
  • Peptide Fragments
  • Salmonella (genetics)
  • Vaccines, Synthetic (administration & dosage, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: